Beijing’s failure to import mRNA Covid jabs ‘mind-boggling’, says BeiGene

Financial Times | Oct 13, 2022 at 1:30 AM
  • …BeiGen’s US-listed shares have fallen 63 per cent over the past 12 months, part of a sector-wide plunge after biotech stocks soared at the start of the coronavirus pandemic….